Case report demonstrates safe surgery outcomes in Charcot-Marie-Tooth patients, highlighting tailored anaesthetic strategies with regional blocks.
Charcot-Marie-Tooth disease (CMT) is one of the most common inherited polyneuropathic disorder occurring due to a genetic mutation, causing distal to proximal muscular weakness. Also known as hereditary motor and sensory neuropathy (HMSN), it may be autosomal dominant, autosomal recessive or X-linked. Anaesthetic management of patients with CMT disease differs from normal patients due to post-operative complications seen after use of muscle relaxants or inhalational agents causing serious complications including prolonged paralysis, respiratory issues or malignant hyperthermia. We report a successfully managed patient with CMT by careful titration of propofol based total intravenous anaesthesia (TIVA) coupled with selective use of regional blocks as a reliable and safe strategy. This tailored anaesthetic approach ensured safety and avoided complications. With vigilant intraoperative management and appropriate anaesthetic choices, surgery can be performed safely in patients with CMT.
No takes yet. Share an insight, caveat, or question.
Devaraju et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: